CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹19,483 Cr | ₹17,763 Cr | ₹17,251 Cr | ₹14,911 Cr | ₹13,951 Cr |
What is the latest Total Expenditure of CIPLA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹19,483 Cr |
| Mar2024 | ₹17,763 Cr |
| Mar2023 | ₹17,251 Cr |
| Mar2022 | ₹14,911 Cr |
| Mar2021 | ₹13,951 Cr |
How is Total Expenditure of CIPLA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹19,483 Cr | 9.68 | |
| Mar2024 | ₹17,763 Cr | 2.96 | |
| Mar2023 | ₹17,251 Cr | 15.70 | |
| Mar2022 | ₹14,911 Cr | 6.88 | |
| Mar2021 | ₹13,951 Cr | - | |
Compare Total Expenditure of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹106,153.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,243.3 Cr | -1.1% | 2.4% | -4.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.8% |
-2.6% |
-9.2% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses